ICI Europe Summit 2018 | 27-29 November 2018 | The Sofitel Berlin Kurfuerstendamm, Berlin

Evidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle

Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development.

Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.

Don’t miss this opportunity to join Merck, Genentech, AstraZeneca, Bayer, Roche and many other leading organisations, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success.

Access the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2Rr4TSI

Pharma Journalist readers are eligible for 10% discount to attend. Book online quoting VIP Code 9710PJ and you’ll automatically receive the discount. Applies to new bookings only. Cannot be used in conjunction with other offers. T&Cs apply.